eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2024
vol. 28
 
Share:
Send email
Share:
Original paper

The effects of tumor-derived exosomes enriched with miRNA-211a on B16F10 cells

Mohammad Reza Atashzar
1
,
Mohammad Reza Ataollahi
2
,
Ali Ghanbari Asad
3
,
Parisa Doroudgar
4
,
Davar Amani
1

  1. Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. Department of Immunology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
  3. Department of Medical Biotechnology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
  4. Department of Oral Medicine, School of Dentistry, Tehran, University of Medical Sciences, Tehran, Iran
Contemp Oncol (Pozn) 2024; 28 (2): 121–129
DOI: https://doi.org/10.5114/wo.2024.142364
Online publish date: 2024/08/23
Article file
- The effects of tumor-derived (1).pdf  [0.29 MB]
Get citation
 
PlumX metrics:
 
1. Schadendorf D, van Akkooi AC, Berking C, et al. Melanoma. Lancet 2018; 392: 971-984.
2. Arnold M, Singh D, Laversanne M, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol 2022; 158: 495-503.
3. Otmani K, Lewalle P. Tumor suppressor miRNA in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications. Front Oncol 2021; 11: 708765.
4. Wozniak M, Mielczarek A, Czyz M. miRNAs in melanoma: tumor suppressors and oncogenes with prognostic potential. Curr Med Chemistry 2016; 23: 3136-3153.
5. Latchana N, Ganju A, Howard JH, Carson III WE. MicroRNA dysregulation in melanoma. Surg Oncol 2016; 25: 184-189.
6. Vand-Rajabpour F, Savage M, Belote RL, Judson-Torres RL. Critical considerations for investigating microRNAs during tumorigenesis: a case study in conceptual and contextual nuances of miR-211-5p in melanoma. Epigenomes 2023; 7: 9.
7. Gajos-Michniewicz A, Czyz M. Role of miRNAs in melanoma metastasis. Cancers 2019; 11: 326.
8. Ray A, Kunhiraman H, Perera RJ. The paradoxical behavior of microRNA-211 in melanomas and other human cancers. Front Oncol 2021; 10: 628367.
9. Dai X, Rao C, Li H, et al. Regulation of pigmentation by micro RNA s: MITF-dependent micro RNA-211 targets TGF-ß receptor 2. Pigment Cell Melanoma Res 2015; 28: 217-222.
10. Sun DS, Guan CH, Wang WN, Hu ZT, Zhao YQ, Jiang XM. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/ VEGF-A axis. Microvasc Res 2021; 134: 104120.
11. Yu X, Odenthal M, Fries JW. Exosomes as miRNA carriers: formation- function-future. Int J Mol Sci 2016; 17: 2028.
12. Ding L, Yang X, Gao Z, et al. A holistic review of the state-of the art microfluidics for exosome separation: an overview of the current status, existing obstacles, and future outlook. Small 2021; 17: 2007174.
13. Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomed 2020; 15: 6917-6934.
14. Chamani A, Doroudgar P, Badri K. Compared the effects of skeletal anchored maxillary protraction vs dental anchored maxillary protraction in children with class III malocclusion: a systematic review and meta-analysis. Int J Pharmaceut Res 2020; 12: 1351-1357.
15. Li S, Xu J, Qian J, Gao X. Engineering extracellular vesicles for cancer therapy: recent advances and challenges in clinical translation. Biomaterial Sci 2020; 8: 6978-6991.
16. Gonda A, Kabagwira J, Senthil GN, Wall NR. Internalization of exosomes through receptor-mediated endocytosis. Mol Cancer Res 2019; 17: 337-347.
17. Seo N, Akiyoshi K, Shiku H. Exosome-mediated regulation of tumor immunology. Cancer Sci 2018; 109: 2998-3004.
18. Hajivalili M, Baghaei K, Mosaffa N, Niknam B, Amani D. Engineering tumor-derived small extra cellular vesicles to encapsulate miR-34a, effectively inhibits 4T1 cell proliferation, migration, and gene expression. Med Oncol 2022; 39: 1-10.
19. Zeng Q, Zhu Z, Song L, He Z. Transferred by exosomes-derived MiR- 19b-3p targets PTEN to regulate esophageal cancer cell apoptosis, migration and invasion. Biosci Rep 2020; 40: BSR20201858.
20. Rezaei R, Baghaei K, Hashemi SM, Zali MR, Ghanbarian H, Amani D. Tumor-derived exosomes enriched by miRNA-124 promote anti-tumor immune response in CT-26 tumor-bearing mice. Front Med 2021; 8: 619939.
21. Hosseini M, Baghaei K, Amani D, Ebtekar M. Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition. DARU J Pharmaceut Sci 2021; 29: 267-278.
22. Zhang D, Lee H, Zhu Z, Minhas JK, Jin Y. Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 2017; 312: L110-l21.
23. Deng X, Cao M, Zhang J, et al. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Biomaterial 2014; 35: 4333-4344.
24. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biol 2007; 9: 654-659.
25. Momen-Heravi F, Bala S, Bukong T, Szabo G. Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomed 2014; 10: 1517-1527.
26. Cheng W, Wang K, Zhao Z, et al. Exosomes-mediated transfer of miR-125a/b in cell-to-cell communication: a novel mechanism of genetic exchange in the intestinal microenvironment. Theranostics 2020; 10: 7561.
27. Sun LH, Tian D, Yang ZC, Li JL. Exosomal miR-21 promotes proliferation, invasion and therapy resistance of colon adenocarcinoma cells through its target PDCD4. Sci Rep 2020; 10: 8271.
28. Wang B, Mao JH, Wang BY, et al. Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-B signaling pathway. Cancer Lett 2020; 489: 87-99.
29. Gonzalez MJ, Kweh MF, Biava PM, et al. Evaluation of exosome derivatives as bio-informational reprogramming therapy for cancer. J Translat Med 2021; 19: 1-10.
30. Zhu L, Kalimuthu S, Gangadaran P, et al. Exosomes Derived from natural killer cells exert therapeutic effect in melanoma. Theranostics 2017; 7: 2732-2745.
31. Zhou J, Yang Y, Wang W, et al. Melanoma-released exosomes directly activate the mitochondrial apoptotic pathway of CD4+ T cells through their microRNA cargo. Exp Cell Res 2018; 371: 364-371.
32. Shen T, Huang Z, Shi C, et al. Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK-mediated endoplasmic reticulum stress. FASEB J 2020; 34: 8442-8458.
33. Wang L, Shen Yf, Shi Zm, Shang Xj, Jin Dl, Xi F. Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thy¬roid tumor cells by downregulating SOX 11. J Clin Lab Anal 2018; 32: e22293.
34. Chen G, Huang P, Xie J, Li R. microRNA 211 suppresses the growth and metastasis of cervical cancer by directly targeting ZEB1. Mol Med Rep 2018; 17: 1275-1282.
35. Yarahmadi S, Abdolvahabi Z, Hesari Z, et al. Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells. Gene 2019; 711: 143939.
36. Venza I, Visalli M, Beninati C, Benfatto S, Teti D, Venza M. IL-10R-expression is post-transcriptionally regulated by miR-15a, miR- 185, and miR-211 in melanoma. BMC Med Genom 2015; 8: 1-9.
37. Naseri Z, Oskuee RK, Jaafari MR, Forouzandeh Moghadam M. Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo. Int J Nanomed 2018; 13: 7727-7747.
38. Chen J, Chen J, Cheng Y, et al. Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation. Stem Cell Res Ther 2020; 11: 1-13.
39. Konishi H, Hayashi M, Taniguchi K, et al. The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy. Cancer Biol Ther 2020; 21: 1128-1135.
40. Yao S, Yin Y, Jin G, et al. Exosome-mediated delivery of miR-204-5p inhibits tumor growth and chemoresistance. Cancer Med 2020; 9: 5989-5998.
41. Gudbergsson, J.M. and K.B. Johnsen, Exosomes and autophagy: rekindling the vesicular waste hypothesis. J Cell Commun Signal 2019; 13: 443-450.
42. Kalra H, Simpson RJ, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 2012; 10: e1001450.
43. Fane ME, Chhabra Y, Smith AG, Sturm RA. BRN 2, a POU erful driver of melanoma phenotype switching and metastasis. Pigment Cell Melanoma Res 2019; 32: 9-24.
44. Xin N, Han M, Shi W, Kang K, Gao C. The expression of miR-211 in cutaneous melanoma and the effect of its overexpression on the proliferation and migration of A375 melanoma cells and on VEGF expression. Int J Clin Exp Med 2021; 14: 1659-1665.
45. Levy C, Khaled M, Iliopoulos D, et al. Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell 2010; 40: 841-849.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
FEATURED PRODUCTS
BOOKS
• Genetyka i leczenie chłoniaka rozlanego z dużych komórek B (DLBCL)
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.